For example, the efficacy of Apolipoprotein A-I (ApoA-I) mimetic peptides in the efflux of HDL from the cell and consequently their therapeutic activity in atherosclerosis has been evaluated (Islam et al. 2020). The gene discussed is APOA1; the disease is atherosclerosis.